Scarica l'app Stockscreener
2.25
4.66%
-0.11
Pre-mercato:
2.28
0.03
+1.33%
Spero Therapeutics Inc Azioni (SPRO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
141.56%
14.19
|
5.874 | 15.04 | 13.47 | 10.20 |
Operating Expenses
|
19.28%
16.63
|
20.61 | 36.77 | 32.06 | 29.26 |
| Benefits Costs and Expenses |
19.51%
15.89
|
19.74 | 116.54 | - | 28.06 |
| Costs And Expenses |
19.51%
15.89
|
19.74 | 31.97 | 32.06 | 28.06 |
| Operating Income/Loss |
83.41%
-2.444
|
-14.73 | -21.73 | -18.59 | -19.06 |
| Nonoperating Income/Loss |
13.99%
0.744
|
0.865 | 1.127 | 1.156 | 1.199 |
| Income/Loss From Continuing Operations Before Tax |
87.74%
-1.70
|
-13.87 | -101.50 | 13.47 | -17.86 |
| Income/Loss From Continuing Operations After Tax |
87.74%
-1.70
|
-13.87 | -20.89 | -17.15 | -17.86 |
|
Net Income/Loss
|
87.74%
-1.70
|
-13.87 | -20.89 | -17.15 | -17.86 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | -0.038 |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | 0.038 |
| Basic Average Shares |
1.17%
56.03
|
55.38 | 0.1681 | 54.12 | 53.96 |
| Diluted Average Shares |
1.17%
56.03
|
55.38 | 0.1681 | 54.12 | 53.96 |
| Basic Earnings Per Share |
88.00%
-0.03
|
-0.25 | -0.38 | -0.32 | -0.33 |
| Diluted Earnings Per Share |
88.00%
-0.03
|
-0.25 | -0.38 | -0.32 | -0.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | -0.038 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):